Sprint Bioscience AB (SPRINT) — Working Capital to Net Assets Ratio
Sprint Bioscience AB (SPRINT) has a Working Capital to Net Assets ratio of 96.7% as of March 2026. Working capital of Skr102.76 Million (current assets of Skr115.45 Million minus current liabilities of Skr12.69 Million) is measured against net assets of Skr106.29 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sprint Bioscience AB Working Capital to Net Assets (2011–2025)
This chart shows how Sprint Bioscience AB's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 96.7%, reflecting working capital of Skr102.76 Million against net assets of Skr106.29 Million SEK. See SPRINT defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Sprint Bioscience AB (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sprint Bioscience AB from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Sprint Bioscience AB assets under control.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.8% | Skr115.39 Million | Skr119.18 Million | Skr132.87 Million | Skr17.48 Million | ▲ +48.7 pp |
| 2024 | 48.1% | Skr4.46 Million | Skr9.27 Million | Skr37.24 Million | Skr32.78 Million | ▼ -35.7 pp |
| 2023 | 83.8% | Skr23.27 Million | Skr27.77 Million | Skr57.87 Million | Skr34.60 Million | ▼ -7.2 pp |
| 2022 | 91.0% | Skr25.65 Million | Skr28.19 Million | Skr34.88 Million | Skr9.23 Million | ▼ -4.5 pp |
| 2021 | 95.5% | Skr67.25 Million | Skr70.45 Million | Skr75.94 Million | Skr8.68 Million | ▲ +7.8 pp |
| 2020 | 87.7% | Skr8.02 Million | Skr9.14 Million | Skr32.27 Million | Skr24.25 Million | ▲ +4.6 pp |
| 2019 | 83.1% | Skr9.15 Million | Skr11.02 Million | Skr17.38 Million | Skr8.23 Million | ▲ +93.1 pp |
| 2018 | -10.0% | Skr-3.73 Million | Skr37.24 Million | Skr18.31 Million | Skr22.05 Million | ▼ -1.1 pp |
| 2017 | -9.0% | Skr-2.52 Million | Skr28.09 Million | Skr4.88 Million | Skr7.40 Million | ▼ -29.6 pp |
| 2016 | 20.7% | Skr5.89 Million | Skr28.49 Million | Skr26.91 Million | Skr21.03 Million | ▲ +237.3 pp |
| 2015 | -216.7% | Skr-10.44 Million | Skr4.82 Million | Skr14.60 Million | Skr25.04 Million | ▼ -274.8 pp |
| 2014 | 58.1% | Skr11.81 Million | Skr20.32 Million | Skr15.09 Million | Skr3.29 Million | ▲ +84.8 pp |
| 2013 | -26.7% | Skr-897.00K | Skr3.36 Million | Skr907.00K | Skr1.80 Million | ▲ +63.2 pp |
| 2012 | -89.9% | Skr-985.89K | Skr1.10 Million | Skr1.72 Million | Skr2.70 Million | ▼ -85.4 pp |
| 2011 | -4.5% | Skr-90.44K | Skr2.03 Million | Skr513.26K | Skr603.70K | — |